Results 131 to 140 of about 118,697 (196)

Acute Inhibition of Adipose Triglyceride Lipase by NG497 Dysregulates Insulin and Glucagon Secretion From Human Islets.

Endocrinology
Kim LB, Liu S, Richtsmeier S, Górniak M, Vikram A, Imai Y.   +5 more
europepmc   +1 more source

A New Era in Obesity Treatment: The Evolution of Antiobesity Medications (AOMs) Based on Clinical Trials. [PDF]

J Diabetes
Liu D, Chen Y.
europepmc   +1 more source

Survodutide: a novel peptide for treatment of obesity and metabolic diseases. [PDF]

Proc (Bayl Univ Med Cent)
Vinton TY.
europepmc   +1 more source

Effects of glucagon and insulin on cytoplasmic protein phosphorylation in hepatocytes

, 1978
Joseph Avruch, Lee A. Witters, M.C. Alexander, Michael A. Bush   +3 more
openalex   +1 more source

Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials. [PDF]

Diabetes Obes Metab
Parker CH, Slattery C, Brennan DJ, le Roux CW.   +3 more
europepmc   +1 more source

Activin B improves glucose metabolism via induction of Fgf21 and hepatic glucagon resistance. [PDF]

Nat Commun
Kobayashi N, Okazaki Y, Iwane A, Hara K, Horikoshi M, Awazawa M, Soeda K, Matsushita M, Sasako T, Yoshimura K, Itoh N, Kobayashi K, Seto Y, Yamauchi T, Aburatani H, Blüher M, Kadowaki T, Ueki K.   +17 more
europepmc   +1 more source

Effect of exercise on Fibroblast Growth Factor 21 levels in healthy males and females. [PDF]

PLoS One
Peterson M, Richardson KA, Funderburk L.
europepmc   +1 more source

RNA-binding proteins: a novel target for modulating glucose and lipid metabolism. [PDF]

Signal Transduct Target Ther
Hu Y, Sun Q.
europepmc   +1 more source

Emerging Treatments for Obesity: the Role of GLP1 Receptor Agonists on Stroke. [PDF]

Curr Neurol Neurosci Rep
Mariscal M, Testai FD.
europepmc   +1 more source